StockFacets
About
Sign-up
Sign-in
Earnings Calendar
Prices are updated after-hours
Published
Previous years
1331
This month
5
This week
1
This year
16
Publishing Date
2024 - 04 - 15
1
2024 - 04 - 10
1
2024 - 04 - 09
1
2024 - 04 - 08
1
2024 - 04 - 03
1
Sector
Health technology
4
Tags
Acquisition
81
Agreement
74
Association
48
Awards
38
Biopharma
42
Business
109
Cancer
88
Ceo
37
Commercial
40
Company
83
Conference
442
Corporation
140
Deadline
75
Earnings
41
Energy
101
Events
44
Expansion
41
Fda
44
Financial
431
First
677
For
559
Global
123
Grants
56
Group
134
Growth
112
Health
80
International
67
Key
81
Management
68
Market
350
Medical
51
Meeting
170
Million
178
N/a
4298
Nasdaq
94
Offering
80
One
62
Partnership
54
Pharmaceuticals
107
Platform
48
Positive
41
Preclinical
39
Program
65
Reach
102
Report
287
Research
146
Results
627
Revenue
46
Sales
44
Services
58
Set
97
Solutions
50
Study
67
System
43
Technology
110
Therapeutics
205
Treatment
71
Trial
89
Update
118
Year
218
Entities
Brainstorm cell therapeutics inc.
2
Coya therapeutics, inc.
1
Sanofi
2
Symbols
BCLI
2
COYA
1
SNY
2
SNYNF
2
Exchanges
Nasdaq
5
Crawled Date
2024 - 04 - 15
1
2024 - 04 - 10
1
2024 - 04 - 09
1
2024 - 04 - 08
1
2024 - 04 - 03
1
Crawled Time
05:00
1
10:00
2
13:30
1
16:00
1
Source
www.biospace.com
2
www.globenewswire.com
1
www.prnewswire.com
2
Sort by:
after hours % change
|
delayed % change
|
gain open
|
gain high
|
gain close
|
publishing date
(GMT-12:00) International Date Line West
(GMT-11:00) American Samoa
(GMT-11:00) Midway Island
(GMT-10:00) Hawaii
(GMT-09:00) Alaska
(GMT-08:00) Pacific Time (US & Canada)
(GMT-08:00) Tijuana
(GMT-07:00) Arizona
(GMT-07:00) Chihuahua
(GMT-07:00) Mazatlan
(GMT-07:00) Mountain Time (US & Canada)
(GMT-06:00) Central America
(GMT-06:00) Central Time (US & Canada)
(GMT-06:00) Guadalajara
(GMT-06:00) Mexico City
(GMT-06:00) Monterrey
(GMT-06:00) Saskatchewan
(GMT-05:00) Bogota
(GMT-05:00) Eastern Time (US & Canada)
(GMT-05:00) Indiana (East)
(GMT-05:00) Lima
(GMT-05:00) Quito
(GMT-04:00) Atlantic Time (Canada)
(GMT-04:00) Caracas
(GMT-04:00) Georgetown
(GMT-04:00) La Paz
(GMT-04:00) Puerto Rico
(GMT-04:00) Santiago
(GMT-03:30) Newfoundland
(GMT-03:00) Brasilia
(GMT-03:00) Buenos Aires
(GMT-03:00) Greenland
(GMT-03:00) Montevideo
(GMT-02:00) Mid-Atlantic
(GMT-01:00) Azores
(GMT-01:00) Cape Verde Is.
(GMT+00:00) Casablanca
(GMT+00:00) Dublin
(GMT+00:00) Edinburgh
(GMT+00:00) Lisbon
(GMT+00:00) London
(GMT+00:00) Monrovia
(GMT+00:00) UTC
(GMT+01:00) Amsterdam
(GMT+01:00) Belgrade
(GMT+01:00) Berlin
(GMT+01:00) Bern
(GMT+01:00) Bratislava
(GMT+01:00) Brussels
(GMT+01:00) Budapest
(GMT+01:00) Copenhagen
(GMT+01:00) Ljubljana
(GMT+01:00) Madrid
(GMT+01:00) Paris
(GMT+01:00) Prague
(GMT+01:00) Rome
(GMT+01:00) Sarajevo
(GMT+01:00) Skopje
(GMT+01:00) Stockholm
(GMT+01:00) Vienna
(GMT+01:00) Warsaw
(GMT+01:00) West Central Africa
(GMT+01:00) Zagreb
(GMT+01:00) Zurich
(GMT+02:00) Athens
(GMT+02:00) Bucharest
(GMT+02:00) Cairo
(GMT+02:00) Harare
(GMT+02:00) Helsinki
(GMT+02:00) Jerusalem
(GMT+02:00) Kaliningrad
(GMT+02:00) Kyiv
(GMT+02:00) Pretoria
(GMT+02:00) Riga
(GMT+02:00) Sofia
(GMT+02:00) Tallinn
(GMT+02:00) Vilnius
(GMT+03:00) Baghdad
(GMT+03:00) Istanbul
(GMT+03:00) Kuwait
(GMT+03:00) Minsk
(GMT+03:00) Moscow
(GMT+03:00) Nairobi
(GMT+03:00) Riyadh
(GMT+03:00) St. Petersburg
(GMT+03:30) Tehran
(GMT+04:00) Abu Dhabi
(GMT+04:00) Baku
(GMT+04:00) Muscat
(GMT+04:00) Samara
(GMT+04:00) Tbilisi
(GMT+04:00) Volgograd
(GMT+04:00) Yerevan
(GMT+04:30) Kabul
(GMT+05:00) Ekaterinburg
(GMT+05:00) Islamabad
(GMT+05:00) Karachi
(GMT+05:00) Tashkent
(GMT+05:30) Chennai
(GMT+05:30) Kolkata
(GMT+05:30) Mumbai
(GMT+05:30) New Delhi
(GMT+05:30) Sri Jayawardenepura
(GMT+05:45) Kathmandu
(GMT+06:00) Almaty
(GMT+06:00) Astana
(GMT+06:00) Dhaka
(GMT+06:00) Urumqi
(GMT+06:30) Rangoon
(GMT+07:00) Bangkok
(GMT+07:00) Hanoi
(GMT+07:00) Jakarta
(GMT+07:00) Krasnoyarsk
(GMT+07:00) Novosibirsk
(GMT+08:00) Beijing
(GMT+08:00) Chongqing
(GMT+08:00) Hong Kong
(GMT+08:00) Irkutsk
(GMT+08:00) Kuala Lumpur
(GMT+08:00) Perth
(GMT+08:00) Singapore
(GMT+08:00) Taipei
(GMT+08:00) Ulaanbaatar
(GMT+09:00) Osaka
(GMT+09:00) Sapporo
(GMT+09:00) Seoul
(GMT+09:00) Tokyo
(GMT+09:00) Yakutsk
(GMT+09:30) Adelaide
(GMT+09:30) Darwin
(GMT+10:00) Brisbane
(GMT+10:00) Canberra
(GMT+10:00) Guam
(GMT+10:00) Hobart
(GMT+10:00) Melbourne
(GMT+10:00) Port Moresby
(GMT+10:00) Sydney
(GMT+10:00) Vladivostok
(GMT+11:00) Magadan
(GMT+11:00) New Caledonia
(GMT+11:00) Solomon Is.
(GMT+11:00) Srednekolymsk
(GMT+12:00) Auckland
(GMT+12:00) Fiji
(GMT+12:00) Kamchatka
(GMT+12:00) Marshall Is.
(GMT+12:00) Wellington
(GMT+12:45) Chatham Is.
(GMT+13:00) Nuku'alofa
(GMT+13:00) Samoa
(GMT+13:00) Tokelau Is.
published :
This month
tags :
Als
save search
Listen Up: Emerging Vocal Biomarker Could Aid ALS Drug Development
Published:
2024-04-15
(Crawled : 05:00)
- biospace.com/
SNYNF
|
News
|
$92.7
0.63%
-2.18%
1.4K
|
Health Technology
|
-0.22%
|
O:
-0.53%
H:
0.61%
C:
0.61%
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
0.29%
|
O:
1.95%
H:
0.0%
C:
0.0%
drug
als
biomarker
BrainStorm Cell Therapeutics Announces Peer-reviewed Publication of Biomarker Data from NurOwn's® Phase 3 Clinical Trial in ALS
Published:
2024-04-10
(Crawled : 10:00)
- prnewswire.com
BCLI
|
$0.5408
2.6%
2.73%
520K
|
Health Technology
|
-28.77%
|
O:
-20.14%
H:
0.0%
C:
0.0%
als
biomarker
publication
cell
trial
therapeutics
BrainStorm Cell Therapeutics Announces Agreement with FDA on a Special Protocol Assessment (SPA) for Phase 3b Trial in ALS
Published:
2024-04-09
(Crawled : 10:00)
- prnewswire.com
BCLI
|
$0.5408
2.6%
2.73%
520K
|
Health Technology
|
-21.33%
|
O:
10.45%
H:
0.0%
C:
0.0%
fda
als
cell
for
trial
therapeutics
agreement
Coya Therapeutics Scientific Advisory Board Chairman Dr. Stanley Appel to Present Updated ALS Biomarker Data at the 2nd Annual Johnson Center Symposium
Published:
2024-04-08
(Crawled : 13:30)
- biospace.com/
COYA
|
$8.24
0.86%
0.37%
75K
|
|
-14.54%
|
O:
-0.21%
H:
2.62%
C:
1.05%
als
symposium
biomarker
therapeutics
AB Science announces that Health Canada has granted eligibility for reconsideration request for masitinib in ALS
Published:
2024-04-03
(Crawled : 16:00)
- globenewswire.com
SNY
|
News
|
$46.11
0.68%
0.7%
3.5M
|
Health Technology
|
-3.33%
|
O:
0.69%
H:
0.0%
C:
0.0%
health
als
granted
canada
Gainers vs Losers
57%
43%
Top 10 Gainers
INVO
|
$1.82
139.47%
56.82%
220M
|
Health Technology
SINT
|
$0.0373
62.88%
37.26%
460M
|
Health Technology
WISA
4
|
$9.25
51.64%
34.27%
64M
|
Electronic Technology
EDBL
|
News
|
$6.66
46.37%
32.39%
13M
|
GCTK
|
$0.715
36.27%
26.62%
600K
|
Manufacturing
TCON
|
$2.29
33.92%
26.61%
1.8M
|
Health Technology
TIRX
|
$0.4848
7.49%
24.58%
5.9M
|
SRFM
4
|
$0.3859
-12.3%
23.84%
660K
|
n/a
KZIA
|
$0.3442
18.28%
23.42%
290K
|
Health Technology
VNDA
|
News
|
$5.24
29.38%
22.56%
24M
|
Health Technology
Your saved searches
Save your searches and get alerts when important news are released.